1. School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, United Kingdom
2. School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo 14040-903. Brazil
3. WuXi AppTec (Wuhan) Co., Ltd., 666 Gaoxin Road, East Lake High-Tech Development Zone, Wuhan 430075, People’s Republic of China
4. Centre for Drug Candidate Optimization, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia
5. Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States
6. Hypha Discovery, 154b Brook Dr, Milton, Abingdon OX14 4SD, United Kingdom
7. UNC Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
8. Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
9. Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
10. Department of Medicinal & Organic Chemistry and Excellence Research Unit of ‘‘Chemistry Applied to Biomedicine and the Environment’’, Faculty of Pharmacy, University of Granada, Campus de Cartuja s/n, 18071 Granada, Spain
11. A. L-M. Cancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh EH4 2XR, United Kingdom
12. Drugs for Neglected Diseases initiative (DNDi), 15 Chemin Camille-Vidart, 1202 Geneva, Switzerland
13. Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41121 Modena, Italy
14. Citizen scientist, New York, New York 11570, United States
15. Cambridge MedChem Consulting, 8 Mangers Lane, Duxford, Cambridge CB22 4RN, United Kingdom
16. Structural Genomics Consortium, University College London, 29-39 Brunswick Square, London WC1N 1AX, United Kingdom